Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-259-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27.7.-11.8.2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- SDA Product (desulphurization of exhaust gases by semi-dry absorption method from the coal fired power plants)
- EC Number:
- 931-259-6
- Molecular formula:
- Not available
- IUPAC Name:
- SDA Product (desulphurization of exhaust gases by semi-dry absorption method from the coal fired power plants)
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): Semi Dry Absorption (SDA) Product
- Molecular formula (if other than submission substance): not available
- Molecular weight (if other than submission substance): not available
Composition of test substance:
Calcium sulphate 6.49 %
Calcium sulphite 41.40 %
Calcium carbonate 29.50 %
Calcium hydroxide 2.27 %
Calcium chloride 17.98 %
Calcium fluoride 0.57 %
Oxides (SiO2 + Al2O3 + Fe2O3 + TiO2) sum 0.97 %
Sum of toxic metals: As, Be, Cd, Co, Cr, Cu, Hg, Mo, Ni, Pb, Sb, Se, Tl, V, Zn sum < 0.1 %
Batch No.: SDA/0609/Sk
Appearance: White solid powder
Stability / Expiration date: 15 years (06/2024)
- Stability under test conditions: stable
- Storage condition of test material: the substance was stored in PE container at room temperature.
- Other: pH 11 approx. (by contact of application form with universal indicator pH strip moistened with water, strip producer Lach-Ner, s.r.o. Neratovice)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: breeding farm VELAZ s.r.o., Koleč u Kladna, Czech Republic, RČH CZ 21760152
- Age at study initiation: 8-10 weeks at the time application
- Weight at study initiation: 134.67-164.12 g
- Fasting period before study: About twenty hours before oral administration the animals were not fed, water was given ad libitum.
- Housing:animal room with monitoring conditions – 3 animals of one sex in one plastic breeding cage Velaz T4
- Bedding: sterilized shavings of soft wood
- Diet: ST 1 BERGMAN – standard pelleted diet ad libitum (producer: Ing.Mrkvička Miroslav - Výroba krmných směsí, Mlýn Kocanda, 252 42 Jesenice u Prahy).
- Water: drinking tap water ad libitum (quality corresponding to Regulation No. 252/2004 Czech Coll. of Law)
- Acclimation period: 5 days
- Randomisation: according to the internal rule, at the start of the study the weight variation of animals was minimal and did not exceed + 20 % of the mean weight for each sex
- Identification of animals: colour marks 1 - 3 on tail of animals, each cage was marked with the number of study, sex and dose of the test substance
- Health condition: certificate of good health condition – from breeding farm; no signs of diseases were observed at clinical check-in, during the acclimatisation period and before the start of study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): room temperature 22 +/- 3°C, permanently monitored
- Humidity (%): relative humidity 30 – 70 %, permanently monitored
- Air changes (per hr): approximately 15 air changes per hour
- Photoperiod (hrs dark / hrs light): light period 12-hour light/12 hour dark
STUDY TIME SCHEDULE
- Animal supply: 22. 7. 2009
- Experimental part of study: 27. 7. - 11. 8. 2009
- Evaluation of results and final report elaboration: 7. 7. - 13. 8. 2009
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Justification for choice of vehicle: It is not toxic. It is possible to prepared homogenous suspension with test substance.
- Batch No.: L803142
- Expiration.: 09/2009
- Producer: Dr. Kulich Pharma Hradec Králové
MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg bw
DOSAGE PREPARATION (if unusual):Immediately before application the test substance was weighed, mixed in vehicle (olive oil) and resulting suspension was administered to the stomach by tube. The single volume of administered suspension was 1ml/100 g of animal body weight.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: according to the methodology
Testing schedule (according to EU Method B.1 tris Annex 1D)
START: 2000 mg/kg – 3 females (Step No.1): no deaths ► 2000 mg/kg – 3 females (Step No. 2): no deaths ► END of study - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 6 females (Step No. 1: 3 females, Step No. 2: 3 females)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were weighed before application, on the 8th day of study and at day 15, before euthanasia of animals. Average body weight in a group was calculated from individual body weights.
- Clinical examination: After application the animals were observed individually:
The first day: twice (30 minutes and 3 hours after application)
The second day: twice (in the morning and in the afternoon) and daily thereafter for 14 days.
Observations included changes in skin and fur, eyes, visible mucous membranes, behaviour of animals, somatomotor activity, reactions to stimuli, and presence of lacrimation, salivation and discharge from nostrils, function of respiratory, digestive and urogenital system.
- Pathological examination
All test animals survived to the end of study were sacrificed on the 15th day by prolonged ether narcosis and gross necropsy was carried out. Nutritious status, body surface, body foramina, thoracic, abdominal and cranial cavity were evaluated. All gross macroscopic changes of organs and tissues were recorded on special data sheets.
- Body weight increments were calculated from body weight at the start of the study, during the first week and at the end of the study.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No animals died during the study.
- Clinical signs:
- other: No clinical signs of intoxication were detected after application in all animals (see tables No. 2 and No. 3). Clinical signs of intoxication (piloerection) were observed in all six animals at the 3 hours after application only.
- Gross pathology:
- The test substance caused no pathological changes in all animals from both groups (see tables No. 4 and No. 5).
Any other information on results incl. tables
Table No. 1: Individual body weight (g) – 2000 mg/kg (Steps No. 1 and No. 2)
Dose (mg/kg) (Step No.) |
Animal No. |
Body weight (g) |
Body weight gain (g) |
||||
Before |
8 days |
15 days |
Death |
0-8 days |
8-15 days |
||
2000 (1) |
1 |
151.50 |
181.27 |
198.26 |
- |
29.77 |
16.99 |
2 |
137.85 |
157.03 |
168.09 |
- |
19.18 |
11.06 |
|
3 |
164.12 |
195.88 |
212.38 |
- |
31.76 |
16.50 |
|
mean |
151.16 |
178.06 |
192.91 |
- |
26.90 |
14.85 |
|
SD |
13.14 |
19.62 |
22.62 |
- |
5.52 |
2.69 |
|
2000 (2) |
4 |
137.86 |
155.80 |
170.35 |
- |
17.94 |
14.55 |
5 |
134.67 |
153.78 |
167.96 |
- |
19.11 |
14.18 |
|
6 |
148.06 |
176.03 |
191.70 |
- |
27.97 |
15.67 |
|
mean |
140.2 |
161.87 |
176.67 |
- |
21.67 |
14.80 |
|
SD |
6.99 |
12.30 |
13.07 |
- |
4.48 |
0.63 |
Table No. 2: Clinical observation – 2000 mg/kg (Step No. 1)
Animal No. |
Death after application |
Observed changes |
1 |
No |
30 minutes: no clinical signs of intoxication 3 hours: piloerection 2nd– 14thday: no clinical signs of intoxication. |
2 |
No |
30 minutes: no clinical signs of intoxication 3 hours: piloerection 2nd– 14thday: no clinical signs of intoxication.. |
3 |
No |
30 minutes: no clinical signs of intoxication 3 hours: piloerection 2nd– 14thday: no clinical signs of intoxication.. |
Table No. 3: Clinical observation – 2000 mg/kg (Step No. 2)
Animal No. |
Death after application |
Observed changes |
4 |
No |
30 minutes: no clinical signs of intoxication 3 hours: piloerection 2nd– 14thday: no clinical signs of intoxication.. |
5 |
No |
30 minutes: no clinical signs of intoxication 3 hours:piloerection 2nd– 14thday: no clinical signs of intoxication. |
6 |
No |
30 minutes: no clinical signs of intoxication 3 hours: piloerection 2nd– 14thday: no clinical signs of intoxication. |
Table No. 4: Pathological examination – 2000 mg/kg (Step No. 2)
Animal No. |
Necropsy findings |
1 |
Without pathologic changes |
2 |
Without pathologic changes |
3 |
Without pathologic changes |
Table No. 5: Pathological examination – 2000 mg/kg (Step No. 2)
Animal No. |
Necropsy findings |
4 |
Without pathologic changes |
5 |
Without pathologic changes |
6 |
Without pathologic changes |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance toxicity was evaluated on the basis of mortality, clinical signs of intoxication, body weight increments during the observation period and necropsy findings at the end of study.
The test substance administered at the dose of 2000 mg/kg caused no death of animals. Clinical signs of intoxication (piloerection) were observed in all six animals at the 3 hours after application only. No pathologic macroscopic changes were diagnosed during pathological examination in all animals. - Executive summary:
The aim of the study was to investigate acute toxic effects of the test substance, Semi Dry Absorption (SDA) Product, after a single oral administration to Wistar rats.
The testing was performed according to the Method B.1 tris: Acute Oral Toxicity - Acute Toxic Class Method, Council Regulation (EC) No.440/2008, published in O.J. L 142, 2008.
The test substance was administered in a single dose as solution in vehicle (olive oil), given orally via gavage to two groups of three female Wistar rats.
The dosing was performed sequentially in two groups of three females: group No. 1 - first step using the starting dose of 2000 mg/kg of body weight and group No.2 - second step using the same dose.
The test substance administered at the dose of 2000 mg/kg caused no death of animals. Clinical signs of intoxication (piloerection) were observed in all six animals at the 3 hours after application only.
No pathologic macroscopic changes were diagnosed during pathological examination in all animals
According to the study results the value of LD50 of the test substance for female rats is higher than 2000 mg/kg of body weight.
The classification of the test substance toxicity was performed according to the Directive 67/548/EEC, Annex VI. part 3.1.5. and 3.2..
Based on the test results and according to the EC criteria for classification and labelling requirements for dangerous substances and preparations the test substance Semi Dry Absorption (SDA) Product, did not fall into any of quoted categories of toxicity and has no obligatory labelling requirement in this respect.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.